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INTRODUCTION
Leishmaniasis is transmitted by the bite of infected female 
phlebotomine sand flies. It is estimated that there are 12 mil-
lion cases of disease worldwide, and there are 0.9-1.3 million 
new cases annually [1]. There are about 20 distinct parasite 
species of Leishmania detected that cause leishmaniasis [2-4]. 
The clinical forms of the disease are wide from a self-limiting 
cutaneous lesion to a mutilating mucocutaneous disease [1,4]. 
World Health Organization (WHO) reported 97 countries as 
endemic leishmaniasis [5]. One of these diseases is cutaneous 
leishmaniasis (CL). Most cases of CL occur in Afghanistan, Al-
geria, Brazil, Colombia, the Islamic Republic of Iran, Pakistan, 
Peru, Saudi Arabia, and Syria [1,6]. In 2015, numbers of re-
ported cases of cutaneous leishmaniasis were particularly high 
in the Islamic Republic of Iran [5]. Iran is one of the most im-
portant endemic areas, in which CL is observed in 2 forms; 
zoonotic CL (ZCL) and anthroponotic CL (ACL). They are 
caused by Leishmania major and Leishmania tropica, respectively 
[4,7]. At present, CL is the most important vector-borne dis-
ease and is seen in many parts of Iran [8,9]. ZCL is endemic in 
17 out of 31 provinces of Iran. One of these provinces is Isfah-
an, which ZCL is endemic in many rural areas [10,11]. Kashan 
is one of the largest cities in Isfahan Province where CL has be-
come widespread. This study was carried out to determine the 
prevalence of this disease in Kashan city in an 8-year period, 
during 2009-2016.
MATERIALS AND METHODS
To examine the prevalence of CL, this cross sectional study 
was carried out during 2009-2016 in the city of Kashan. The 
data of 2,676 CL cases referred to health centers of Kashan 
University of Medical Sciences were collected. The patients 
were introduced to the laboratory by physician after an early-
detection examination. For the diagnosis of CL, the direct 
smear technique has been used. The samples were taken from 
patient's lesions by clinical staff and then examined under a 
light microscope for signs of Leishman parasite. All data ob-
tained were recorded in researcher-constructed checklists and 
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the SPSS version 24 (Chicago, Illinois, USA) for Windows was 
used to perform a chi-square test for relationships between 
variables. The checklist used included patients' demographic 
characteristics such as age, gender, occupation, place or num-
ber of acute lesion(s), date of occurrence of lesion(s), history 
of travel in the past to other endemic foci of the disease, loca-
tion of residence, results of clinical examination and laborato-
ry tests, the type of treatment regimen, and nationality of pa-
tients. Data were analyzed using SPSS version 24 for windows.
RESULTS
During the 8-year period (2009-2016), total 2,676 cases of 
CL were reported. Of these, 42% were female and 58% were 
male. The chi-square test showed that there was no significant 
association between the sex and the disease (P>0.05). The dis-
ease had the highest frequency (20.9%) in 20-29 age groups 
and the lowest (8.9%) were seen in 50-59 age groups. No sig-
nificant correlation was found between age groups and active 
disease. Among the patients, 51.6% were under 30 years old 
(Table 1). Only 1.1% were 1-year-old or less. The youngest was 
only 1-month old, and the oldest patient was 95 years old. 
The location of lesions was different; 61.5% of the patients 
had a lesion on their hands, 18.1% on face, 16.4% on feet, 
2.4% on trunk, and 1.6% in other places of the body. About 
1/3 (37.3%) of these patients had multiple lesions spread all 
over their bodies. A maximum of 20 wounds were seen in 1 
patient. Also, most patients (62.7%) had a single lesion. Most 
patients (91.7%) lived in urban areas (P=0.001). The highest 
rate of lesion according to the occupation was observed in 
housewives (27.2%). There was no significant relationship be-
tween the occupation and disease (P=0.062). The most com-
mon location of lesions was on hands (61.4%) and then on 
face (16.4%), on feet (16.4%) and on the other parts of the 
body (Table 1). Some (39.3%) cases had a history of travel to 
endemic areas, and 92% and 8% were living in urban and ru-
ral areas, respectively. 
Table 1. Distribution of cutaneous leishmaniasis (CL) disease 
characters in 2,676 patients in the city of Kashan, 2009-2016 
Characters Categories
No. (%) of 
patients with CL
Year 2009
2010
2011
2012
2013
2014
2015
2016
562 (21.0)
395 (14.8)
316 (11.8)
348 (13.0)
299 (14.9)
377 (14.1)
203 (7.6)
176 (6.6)
Gender Male
Female
1,550 (58.0)
1,126 (42.0)
Age group 0-9
10-19
20-29
30-39
40-49
50-59
≥  60
365 (13.6)
457 (17.1)
558 (20.9)
380 (14.2)
335 (12.5)
238 (8.9)
343 (12.8)
Occupation Housewife
Student
Worker
Child
Farmer
Driver
Other
727 (27.2)
482 (18.0)
354 (13.2)
249 (9.3)
94 (3.5)
48 (1.8)
722 (27.0)
Location of residence Urban
Rural
2,455 (91.7)
221 (8.3)
Nationality Iranian
Non-Iranian
2,402 (89.8)
274 (10.2)
Travel history Yes
No
1,053 (39.3)
1,623 (60.7)
Season Spring
Summer
Autumn
Winter
485 (18.1)
534 (20.0)
1,134 (42.4)
523 (19.5)
Place of Lesion Hands
Feet
Face
Trunk
Other places
1,646 (61.5)
441 (16.4)
487 (18.1)
64 (2.4)
44 (1.6)
Treatment Systemic glucantime
Topical glucantime
Topical glucantime & 
 Cryotherapy
Cryotherapy
Not indicated
Other
2,183 (81.6)
306 (11.4)
43 (1.6)
102 (3.8)
13 (0.5)
29 (1.1)
Fig. 1. Cutaneous leishmaniasis (CL) disease annual incidence 
rate per 100,000 populations in the city of Kashan between 2009- 
2016.
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The highest number of cases (21%) was seen in 2009 and 
the lowest (6.6%) in 2016 (Table 1). The highest annual inci-
dence was estimated to be 182 per 100,000 in 2009 and the 
least was 47 per 100,000 in 2016 (Fig. 1). The most frequent 
prevalence of cases was seen in autumn (42.4%), and the least 
was seen in spring (18.1%). Most of the patients (81.6%) were 
treated by systemic glucantime regimen (Table 1). There was a 
significant difference between the treatment regimen and the 
disease (P=0.000).
DISCUSSION
This report aimed to provide epidemiological information 
on CL in city of Kashan over the past 8 years (2009-2016). 
During this period, total 2,676 CL cases were detected. In re-
cent years, the incidence of CL showed a significant decrease; 
however, CL is still a public health problem. 
In this study, both sexes were susceptible to the disease. 
However, the incidence of the disease was more common in 
the male gender (58%). Other investigations in Iran, Kerman-
shah and Fars Province, reported similar findings [12-15]. 
Higher incidence of the disease in men could be due to multi-
ple factors such as habits of wearing clothes, business, travel to 
endemic regions, inadequate health education, environmental 
factors, and vector related factors. In relation with the occupa-
tional groups, the highest frequency (27.2%) was observed in 
housewives. Our findings were consistent with the results of 
the studies in Qom Province and in urban and rural provinces 
in Iran [10,13]. The higher levels of contamination in house-
wives can be attributed to economic activities related to carpet 
weaving. Many housewives are knitting handmade carpet in 
low-light basements or rooms. Sandflies can continue blood-
sucking activities under this condition throughout the day [4]. 
Our study showed that the highest incidence of CL occurred in 
20-29 year-old age group. Findings in Kermanshah, Fars Prov-
ince and Kashan were consistent with the results of the present 
study [14-16]. However, our results were inconsistent with 
studies performed in Qom, Razavi Khorasan, south western 
Iran [10,17,18]. In the Kashan region, Since the reservoir hosts 
and humans contacts with sandflies are high and the endemic-
ity of CL is low; the disease occurred in all age groups, and the 
disease was more common in the age group of 20-29 years 
(20.9%).
Regarding the seasonal tendency, we found that the highest 
prevalence occurred in autumn. Our result is consistent with 
findings in Qom, Fars Province and Yazd studies [10,14,19]. 
However, in Kermanshah, the majority of CL were observed in 
winter [15]. This finding is inconsistent with the result of the 
current study. Increase of CL cases in autumn can be associated 
with the incubation period of the disease, climatic conditions, 
sandfly peak activities, and blood-sucking of the victims.
The CL lesions may occur in any part of the body, and there 
are various reports on unusual sites [7,21]. In this study, the 
most common place was hands (61.4%). Our findings are 
similar to the results of 2 studies in Iran and the cities of 
Kashan and Ahvaz [12,13,16,20]. Since hands are often un-
coated and easily exposed to infected female sandfly bites, 
hands show a higher frequency of lesions than other parts of 
the body.
In the present study, 62.7% patients had only 1 lesion. Since 
37.3% patients had 2 or more lesions, we could conclude that 
the victim has one or more time bites by sandflies. In addi-
tion, we observed that 39.3% of patients had a history of travel 
to endemic regions. Therefore, the majority of patients 
(60.7%) have been infected in the place of residence. 
We found out that the most preferred treatment regimen 
(81.6%) is systemic meglumine antimonate (Glucantime). 
This is not consistent with the results of a study conducted in 
Libya [22]. Since pentavalent antimony compounds are the 
first line drug against all forms of leishmaniasis [23], this treat-
ment regimen was taken by physicians for treating CL lesions 
in the city of Kashan. Antimony compounds have some limi-
tations, such as toxicity, resistance, and long duration of treat-
ment. To cover these disadvantages, investigators are trying to 
evaluate different compounds [24].
The highest incidence of CL was estimated in 2009 (182 per 
100,000 people) and the least in 2016 (47 per 100,000 peo-
ple). The results of a study conducted in Iran showed that the 
incidence of CL was 27.5 per 100,000 populations [13]. The 
incidence of CL in the city of Kashan was higher than expected 
and compared with the prevalence of CL in Iran. The CL inci-
dence has declined in the last 2 years (2015-2016). The declin-
ing trend might be due to significant activities undertaken in 
CL control program, including control of the parasite vectors 
and reservoir hosts, early diagnosis and treatment of the dis-
ease, and increasing people's awareness on the use of personal 
protection methods. The results of our study confirmed that 
CL is endemic in many parts of rural and urban areas of 
Kashan district. According to many reasons, including socio-
economic and psychological problems, the disease should be 
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controlled. To control the disease, much attention should be 
given to improve the environment conditions and public 
health education.
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